查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1453996

2030年註射细胞毒性药物的市场预测：按药物类型、分销管道、应用和地区进行的全球分析

Injectable Cytotoxic Drugs Market Forecasts to 2030 - Global Analysis By Drug Type, Distribution Channel, Application, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球注射细胞毒性药物市场规模为 189 亿美元，预计在预测期内将以 7.4% 的复合年增长率增长，到 2030 年达到 311 亿美元。

注射细胞毒性药物是透过注射给药的药物，透过靶向和破坏快速分裂的癌细胞来治疗各种癌症。这些药物透过抑制细胞分裂过程、诱导细胞死亡和抑制肿瘤生长来发挥作用。它经常用于化疗方案，包括胺甲喋呤、阿霉素和长春新碱等药物。儘管有副作用，注射细胞毒性药物在癌症治疗中至关重要，通常单独使用或与其他治疗方法合併使用，以缩小肿瘤、预防转移并提高患者的存活率。

医疗保健支出增加

随着医疗保健预算的扩大，获得先进癌症治疗方法（包括注射细胞毒性药物）的机会也在增加。支出的增加将使医疗保健系统能够为诊断为癌症的患者采购并提供更广泛的治疗选择。此外，医疗保健设施设备齐全，可容纳注射细胞毒性药物的储存、给药和给药，进一步促进它们在癌症治疗方法中的使用，从而进一步推动该市场的发展。

开发成本高

新细胞毒性药物的开发需要广泛的临床前研究、临床试验和监管部门的核准，而该过程的每一步都会产生巨大的成本，给製药公司带来了巨大的财务负担。此外，获得美国FDA和欧洲EMA等监管机构的核准并满足监管要求会增加开发成本并阻碍市场开拓。

药物开发的进展

药物製剂技术的进步正在开发更稳定且生物可利用的细胞毒性药物製剂，以改善药物传递和组织渗透。这些进步涵盖了药物发现、配方和递送的各个方面，并有助于开发更安全、更有效的细胞毒性疗法。此外，这些方法使研究人员能够识别对癌细胞具有增强选择性和效力的化合物，同时最大限度地减少脱靶效应，从而有可能增加我们正在进一步推广的市场潜力。

副作用和毒性

儘管这些药物可以有效地针对快速分裂的癌细胞，但它们常常会产生副作用，影响患者的生活品质和治疗依从性。注射细胞毒性药物的常见副作用包括噁心、呕吐、掉髮、疲劳和免疫抑制。此外，患者还可能因接触细胞毒性药物而出现长期併发症，例如继发性癌症和器官损伤，这阻碍了市场的规模。

COVID-19 的影响

COVID-19 大流行对注射细胞毒性药物市场产生了一些负面影响。全球医疗保健系统的中断导致癌症筛检、诊断和治疗的延误，导致患者数量下降。此外，封锁、旅行限制和供应链中断的后勤挑战正在阻碍注射细胞毒性药物的生产、分销和交付。这进一步影响了患者获得注射细胞毒性药物的机会，特别是在资源有限的环境中，严重阻碍了这个市场。

长春花生物碱部分预计将在预测期内成为最大的部分

由于长春花生物碱在癌症治疗中的关键作用，估计其份额最大。这些药物透过抑制微管形成来抑制细胞分裂并诱导快速分裂的癌细胞凋亡。此外，正在进行的研究和开发旨在优化长春花生物碱的治疗功效，同时最大限度地减少副作用，从而推动这一领域的扩张。

预计多发性硬化症领域在预测期内将经历最高的复合年增长率

由于其显着成长和技术创新，预计多发性硬化症领域在预测期内将出现最高的复合年增长率。干扰素β 1a 和干扰素β 1b 药物有助于调节免疫系统的反应，减少多发性硬化症患者的发炎和復发频率。此外，新的治疗药物，例如针对特定免疫途径的单株抗体，正在扩大多发性硬化症患者的治疗选择，并推动该领域的成长。

比最大的地区

由于北美癌症和多发性硬化症等自体免疫疾病的盛行率很高，因此全部区域对注射细胞毒性药物的需求量很大。该地区受益于发达的医疗基础设施、先进的医疗设施和高水准的医疗保健支出。此外，有利的报销政策和保险范围有助于患者获得这些基本药物，支持该地区的扩张。

复合年增长率最高的地区：

由于欧洲拥有强大的製药业、尖端研究和坚实的医疗基础设施，预计在预测期内复合年增长率最高。在欧洲，学术界、工业界和监管机构之间的合作正在促进创新并加速研究成果的临床转化。此外，欧洲正在采用新的药物传输技术，提高注射细胞毒性药物的治疗效果和安全性，进一步推动该地区的发展。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球注射细胞毒性药物市场：依药物类型

  • 长春花生物碱
  • 细胞週期蛋白
  • 烷化剂
  • 紫杉烷
  • 抗代谢物
  • 铂化合物
  • 其他药物类型

第六章全球注射细胞毒性药物市场：按分销管道

  • 零售药房
  • 网路药房
  • 医院药房
  • 癌症专科中心
  • 其他分销管道

第七章全球注射细胞毒性药物市场：依应用分类

  • 肿瘤学
  • 多发性硬化症
  • 类风湿性关节炎
  • 其他用途

第八章全球注射细胞毒性药物市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Merck & Co. Inc.
  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Amgen, Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Sanofi
  • Johnson and Johnson Services Inc.
  • Abbie Inc
  • Novartis AG
Product Code: SMRC25548

According to Stratistics MRC, the Global Injectable Cytotoxic Drugs Market is accounted for $18.9 billion in 2023 and is expected to reach $31.1 billion by 2030 growing at a CAGR of 7.4% during the forecast period. Injectable cytotoxic drugs refer to medications administered via injection to treat various cancers by targeting and destroying rapidly dividing cancer cells. These drugs work by interfering with cell division processes, inducing cell death, or inhibiting tumor growth. Often used in chemotherapy regimens, they include agents like methotrexate, doxorubicin, and vincristine. Despite their side effects, injectable cytotoxic drugs are crucial in cancer treatment, often used alone or in combination with other therapies to shrink tumors, prevent metastasis, and improve patients' overall survival rates.

Market Dynamics:

Driver:

Increasing healthcare expenditure

As healthcare budgets expand, there's greater accessibility to advanced cancer treatments, including cytotoxic drugs administered via injection. This increased spending enables healthcare systems to procure and offer a wider range of treatment options to patients diagnosed with cancer. Moreover, healthcare facilities are better equipped to handle the storage, administration, and management of injectable cytotoxic drugs, further facilitating their use in cancer treatment regimens and propelling this market further.

Restraint:

High development costs

Developing a new cytotoxic drug involves extensive preclinical studies, clinical trials, and regulatory approvals, which incur significant expenses at each stage of the process and contribute to substantial financial burdens for pharmaceutical companies. Moreover, navigating regulatory requirements and obtaining approvals from regulatory agencies such as the FDA in the United States and the EMA in Europe adds to the development costs, thereby gradually impedes this market growth.

Opportunity:

Advancements in drug development

Advancements in drug formulation technologies have led to the development of more stable, bioavailable cytotoxic drug formulations that improve drug delivery and tissue penetration. These advancements encompass various aspects of drug discovery, formulation, and delivery, contributing to the development of safer, more efficacious cytotoxic therapies. Moreover, these approaches enable researchers to identify compounds with enhanced selectivity and potency against cancer cells while minimizing off-target effects, propelling this market further.

Threat:

Side effects and toxicity

These medications, while effective in targeting rapidly dividing cancer cells, often lead to adverse effects that impact patients' quality of life and treatment adherence. Common side effects of injectable cytotoxic drugs include nausea, vomiting, hair loss, fatigue, and immunosuppression. Moreover, patients may also develop long-term complications from cytotoxic drug exposure, including secondary cancers and organ damage, which hinder this market size.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the injectable cytotoxic drug market. Disruptions in healthcare systems worldwide have led to delays in cancer screenings, diagnoses, and treatments, resulting in a reduction in the number of patients. Furthermore, logistical challenges arising from lockdowns, travel restrictions, and supply chain disruptions have hampered the production, distribution, and delivery of injectable cytotoxic drugs. This has further impacted patient access to injectable cytotoxic drugs, particularly in resource-limited settings, which significantly hinders this market.

The vinca alkaloids segment is expected to be the largest during the forecast period

The vinca alkaloids segment is estimated to hold the largest share, due to its pivotal role in cancer treatment. These drugs work by disrupting microtubule formation, thereby inhibiting cell division and inducing apoptosis in rapidly dividing cancer cells. Additionally, ongoing research and development efforts aim at optimizing Vinca alkaloids' therapeutic benefits while minimizing adverse effects, thereby boosting this segment's expansion.

The multiple sclerosis segment is expected to have the highest CAGR during the forecast period

The multiple sclerosis segment is anticipated to have highest CAGR during the forecast period due to its significant growth and innovation. Interferon beta-1a and interferon beta-1b drugs help regulate the immune system's response, reducing inflammation and the frequency of relapses in MS patients. Moreover, emerging therapies, including monoclonal antibodies targeting specific immune pathways, are expanding treatment options for MS patients, which is driving this segment's growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period, owing to the high prevalence of cancer and autoimmune diseases such as multiple sclerosis, there is a substantial demand for injectable cytotoxic drugs across the region. The region benefits from a well-established healthcare infrastructure, advanced medical facilities, and a high level of healthcare spending. Furthermore, favorable reimbursement policies and insurance coverage contribute to patients' access to these essential medications, propelling this region's expansion.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to the region's strong pharmaceutical industry, cutting-edge research, and robust healthcare infrastructure. Collaborative efforts between academia, industry, and regulatory agencies in Europe foster innovation and accelerate the translation of research findings into clinical practice. In addition, Europe has witnessed the adoption of novel drug delivery technologies, enhancing the therapeutic efficacy and safety profile of injectable cytotoxic drugs, which drives this region further.

Key players in the market

Some of the key players in the Injectable Cytotoxic Drugs Market include Merck & Co. Inc., Pfizer, Inc., F. Hoffmann-La Roche Ltd., Amgen, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi, Johnson and Johnson Services Inc. , Abbie Inc, Novartis AG.

Key Developments:

In February 2024, Novartis announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a Germany-based, global biopharmaceutical company developing innovative medicines in oncology.

In July 2023, DTx Pharma, a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide platform, announced that it has been acquired by Novartis.

Drug Types Covered:

  • Vinca Alkaloids
  • Anthracyclines
  • Alkylating Agents
  • Taxanes
  • Antimetabolites
  • Platinum Compounds
  • Other Drug Types

Distribution Channel Covered:

  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Specialty Cancer Centers
  • Other Distribution Channels

Applications Covered:

  • Oncology
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Injectable Cytotoxic Drugs Market, By Drug Type

  • 5.1 Introduction
  • 5.2 Vinca Alkaloids
  • 5.3 Anthracyclines
  • 5.4 Alkylating Agents
  • 5.5 Taxanes
  • 5.6 Antimetabolites
  • 5.7 Platinum Compounds
  • 5.8 Other Drug Types

6 Global Injectable Cytotoxic Drugs Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Retail Pharmacies
  • 6.3 Online Pharmacies
  • 6.4 Hospital Pharmacies
  • 6.5 Specialty Cancer Centers
  • 6.6 Other Distribution Channels

7 Global Injectable Cytotoxic Drugs Market, By Application

  • 7.1 Introduction
  • 7.2 Oncology
  • 7.3 Multiple Sclerosis
  • 7.4 Rheumatoid Arthritis
  • 7.5 Other Applications

8 Global Injectable Cytotoxic Drugs Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Merck & Co. Inc.
  • 10.2 Pfizer, Inc.
  • 10.3 F. Hoffmann-La Roche Ltd.
  • 10.4 Amgen, Inc.
  • 10.5 Bristol-Myers Squibb Company
  • 10.6 Eli Lilly and Company
  • 10.7 Sanofi
  • 10.8 Johnson and Johnson Services Inc.
  • 10.9 Abbie Inc
  • 10.10 Novartis AG

List of Tables

  • Table 1 Global Injectable Cytotoxic Drugs Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 3 Global Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 4 Global Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 5 Global Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 6 Global Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 7 Global Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 8 Global Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 9 Global Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 10 Global Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 11 Global Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 12 Global Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 13 Global Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 14 Global Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 15 Global Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 16 Global Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 18 Global Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 19 Global Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 20 Global Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 North America Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 23 North America Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 24 North America Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 25 North America Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 26 North America Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 27 North America Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 28 North America Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 29 North America Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 30 North America Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 31 North America Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 32 North America Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 33 North America Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 34 North America Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 35 North America Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 36 North America Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 37 North America Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 38 North America Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 39 North America Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 40 North America Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Europe Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 43 Europe Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 44 Europe Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 45 Europe Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 46 Europe Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 47 Europe Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 48 Europe Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 49 Europe Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 50 Europe Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 51 Europe Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 52 Europe Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 53 Europe Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 54 Europe Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 55 Europe Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 56 Europe Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 57 Europe Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 58 Europe Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 59 Europe Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 60 Europe Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 61 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 63 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 64 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 65 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 66 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 67 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 68 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 69 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 70 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 71 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 72 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 73 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 74 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 75 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 76 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 77 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 78 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 79 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 80 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 81 South America Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 83 South America Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 84 South America Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 85 South America Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 86 South America Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 87 South America Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 88 South America Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 89 South America Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 90 South America Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 91 South America Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 92 South America Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 93 South America Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 94 South America Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 95 South America Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 96 South America Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 97 South America Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 98 South America Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 99 South America Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 100 South America Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 101 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 103 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 104 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 105 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 106 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 107 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 108 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 109 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 110 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 111 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 112 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 113 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 114 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 115 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 116 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 117 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 118 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 119 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 120 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)